Why do we have Speaker Compliance Guidelines and Training?
|
|
|
- Alvin Bishop
- 10 years ago
- Views:
Transcription
1
2 Disclaimer The views expressed in this presentation are the views of the facilitators and do not necessarily represent the views or policies of our employer.
3
4
5 Why do we have Speaker Compliance Guidelines and Training? Pharmaceutical companies are responsible for activities conducted by or on behalf of that Company Considerations when engaging Speakers/Consultants: Speakers are acting on behalf of your Company Speakers are held to the same regulatory standards as your Company employees Speakers should only use your Company approved slide deck and materials Speakers should have fully executed contract in place with your Company 5
6
7 FDA Monitoring The FDA monitors company controlled activities by the pharmaceutical industry, examples include: Including complaints from speaker program attendees regarding inappropriate activities FDA s Bad Ad Program The FDA has cited companies and speakers for violations made by their speakers Such letters are made public on the FDA website
8 The Compliance Environment Compliance policies are based on government laws, regulations, industry codes and company guidelines Non-compliance can result in: Industry Fines Corporate Integrity Agreements (CIA) Government exclusion from federal health care programs (Medicare and Medicaid)
9
10 Criteria, criteria, criteria What does the selection process look like within your company? Where do speaker recommendations originate? How has Open Payments impacted speaker availability? Expected qualifications well documented? National/Regional/Local designations? Minimum requirements for continued participation?
11 Example Selection Process Criteria National Faculty Criteria Tier 1 Tier 2 Tier 3 Primary Considerations: -Years since Post Graduate Completion Professional Organizations (medically related) Presentations (includes promo, grand rounds, CME, etc.) Publications (includes articles & abstracts) Research experiences/trials Yes Yes No Optional Considerations: -Academic Appointments Yes Yes No -Previous Speaker Bureau experience (any company) Yes Yes No Minimum # of Qualifications Met: Minimum Primary Criteria Met
12
13 Speaker training, what does it look like? Who in your company is responsible for designing, creating and executing Speaker Training? Is there a standardized process? How is it executed? Live, virtual, other? How are you addressing scenarios where speakers cannot attend training? How are they trained to handle: Unsolicited off-label questions? Questions regarding reimbursement? Reports of Adverse Events or Product Quality Complaints? How do you handle speaker requests to modify or add slides? Speaker provides an additional handout to the audience, not company approved
14 Purpose of Programs GOAL Provide Truthful, Balanced and Accurate information about our company products to Health Care Professionals and Patients Promotional speakers : Remain on-label Provide information that is truthful and not false/misleading Provide fair-balance with product risk/benefit Only use the slide deck approved and provided by the Company Not solicit off-label inquiries
15 What is Considered Off-Label? Information not consistent with the FDA-approved PI is considered off-label Although physicians may prescribe or use products for off-label uses, the FDA currently prohibits pharmaceutical companies, and consequently any employees or representatives engaged in selling or marketing the Company's products, to promote those unapproved, or off-label uses
16 Program Watch Outs Promotional Speakers : Proactively discuss off-label use of the product Broaden of product indication Present data out of context Minimize safety issues Omit material information Compare efficacy or safety claims without substantial evidence Overstate efficacy or safety
17
18 Employee Training Beyond the standard HCC training, does your company conduct additional training for employees regarding Speaker Programs? What resources or tools do you make available? Does on-the-job training come into play? If so, is it standardized?
19
20 Summary: Company Representatives Provide attendees with Package Insert or company approved materials with Package Insert Should not interject while speaker is presenting approved content or solicit speaker to discuss off-label information Address speaker should he or she solicit discussions on off-label information Complete the speaker evaluation Report any non-compliance to manager and Health Care Compliance Officer immediately.
21
22 Mitigating Risks What safeguards do you have established regarding compliant speaker programs? Observations what is your process? How are observations allocated? Risk based?? Who conducts observations? How are they trained? Process for scheduling? Heads up vs. show up? Third-Party Vendor what is the scope of their role in this process? Other ways to mitigate risk?
23
WALKING THE COMPLIANCE LINE: A REGULATORY LAWYER S PERSPECTIVE
WALKING THE COMPLIANCE LINE: A REGULATORY LAWYER S PERSPECTIVE Presented By: Alan B. Minsk Partner and Chair, Food and Drug Practice Team Arnall Golden Gregory LLP [email protected] Presented To: ISMPP
Business Conduct Standards for Interactions with Healthcare Professionals. Pocket Guide for U.S. Sales Professionals. Do The Right Thing
Business Conduct Standards for Interactions with Healthcare Professionals Pocket Guide for U.S. Sales Professionals Do The Right Thing As Amgen s Vice President of Sales and Marketing Operations and Planning,
Bayer HealthCare s Comprehensive Compliance Program Pursuant to California Health and Safety Code 119400-119402
Bayer HealthCare s Comprehensive Compliance Program Pursuant to California Health and Safety Code 119400-119402 I. INTRODUCTION Bayer HealthCare LLC [including Bayer HealthCare LLC Dermatology Division
U.S. PHARMACEUTICALS COMPLIANCE AND ETHICS CODE OF CONDUCT
U.S. PHARMACEUTICALS COMPLIANCE AND ETHICS CODE OF CONDUCT Effective: January 1, 2009 U.S. PHARMACEUTICALS COMPLIANCE AND ETHICS CODE OF CONDUCT January 1, 2009 I. INTRODUCTION Table of Contents II. COMPLIANCE
Code of Conduct. Compliance W.I.N.S Worldwide Integrity is Necessary for Success
Code of Conduct Compliance W.I.N.S Worldwide Integrity is Necessary for Success Effective February 2014 Disclaimer BEFORE YOU BEGIN You are being provided this certification to assist you in meeting your
Amgen GLOBAL CORPORATE COMPLIANCE POLICY
1. Scope Applicable to all Amgen Inc. and subsidiary or affiliated company staff members, consultants, contract workers and temporary staff worldwide ( Covered Persons ). Consultants, contract workers,
Keeping our Focus: Compliance Summary for Customers and Health Care Professionals. Understanding the Olympus Health Care Compliance Code of Conduct
Keeping our Focus: Compliance Summary for Customers and Health Care Professionals Understanding the Olympus Health Care Compliance Code of Conduct Introduction Olympus Corporation of the Americas ( Olympus
DUVAL CLIENT ALERT December 2009
1 P a g e DUVAL CLIENT ALERT December 2009 In this DUVAL CLIENT ALERT, we list practical ways medical device companies can lawfully communicate about their products prior to FDA clearance or approval.
Orange Guide (also known as the Field Guide)
Pfizer Inc 235 East 42nd Street New York, NY 10017 www.pfizer.com Dear Colleagues: At Pfizer, we are committed to upholding the highest standards when we interact with physicians, healthcare organizations,
Use of Social Media by Pharmaceutical Medical Information Teams
www.arisglobal.com A White Paper Presented By ArisGlobal Use of Social Media by Pharmaceutical Medical Information Teams Ome Ogbru, PharmD, Medical Information SME What is Social Media? The Merriam-Webster
Introduction to Compliance with FDA Labeling and Advertising Requirements
Introduction to Compliance with FDA Labeling and Advertising Requirements Second Annual Pharmaceutical Industry Regulatory and Compliance Summit Dick Kenny FDA History Basic function of government Oldest
A PASSION FOR INTEGRITY. Every Day Health Care Compliance. Code of Conduct
A PASSION FOR INTEGRITY Every Day Health Care Compliance Code of Conduct Health Care Compliance Is Everyone s Responsibility Johnson & Johnson Pharmaceutical Affiliates are known the world over for innovative,
University of Central Florida College of Medicine Industry Relations Policy and Guidelines. Table of Contents
University of Central Florida College of Medicine Industry Relations Policy and Guidelines 1. Introduction and Scope of Policy 2. Statement of Policy Table of Contents 3. Gifts and Individual Financial
Fraud, Waste and Abuse Training
Fraud, Waste and Abuse Training 1 Why Do I Need Training? Every year millions of dollars are improperly spent because of fraud, waste and abuse. It affects everyone, Including YOU. This training will help
CORPORATE INTEGRITY AGREEMENT
CORPORATE INTEGRITY AGREEMENT BETWEEN THE OFFICE OF INSPECTOR GENERAL OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES AND GLAXOSMITHKLINE LLC I. PREAMBLE (GSK) hereby enters into this Corporate Integrity
LIBRARY GUIDE: Medical Device Sales & Marketing
LIBRARY GUIDE: Medical Device Sales & Marketing Page 2 Table of Contents Overview... 2 About Our Health Care Compliance Solution... 2 Our Relationship With AdvaMed... 2 Course Descriptions: Basics of the
PhRMA Code on Interactions with Healthcare Professionals
PhRMA Code on Interactions with Healthcare Professionals Preamble The Pharmaceutical Research and Manufacturers of America (PhRA4.A) represents research-basedpharmaceutical and biotechnology companies.
3. HEALTH, SAFETY AND ENVIRONMENTAL PROTECTION
1. PURPOSE It is the goal of UCB, Inc. (UCB) to ensure that its marketing and promotional activities comply with all applicable state and federal laws. In addition, UCB Inc. endeavors to conform to pertinent
Meeting the HIPAA Training and Business Associate Requirements Questions and Answers, with HIPAA Security Expert Mike Semel
Meeting the HIPAA Training and Business Associate Requirements Questions and Answers, with HIPAA Security Expert Mike Semel Questions Answers 1 Is a Business Associate (BA) responsible for assuming a Covered
Medicare Advantage and Part D Fraud, Waste, and Abuse Training. October 2010
Medicare Advantage and Part D Fraud, Waste, and Abuse Training October 2010 Introduction 2008: United States spent $2.3 trillion on health care. Federal fiscal year 2010: Medicare expected to cover an
Fraud Waste and Abuse Training Requirement. To Whom It May Concern:
RE: Fraud Waste and Abuse Training Requirement To Whom It May Concern: This letter is to inform you about a new requirement being implemented by the CMS program (Centers for Medicare and Medicaid Services)
The Chairman s Message on Health Care Compliance
904438_JnJ_EmpGde 9/17/09 8:37 AM Page FC2 The Chairman s Message on Health Care Compliance Johnson & Johnson is known the world over for innovative, life-saving medical products and for the values we
CORNERSTONE THERAPEUTICS INC. SECOND AMENDED AND RESTATED CODE OF BUSINESS CONDUCT AND ETHICS
CORNERSTONE THERAPEUTICS INC. SECOND AMENDED AND RESTATED CODE OF BUSINESS CONDUCT AND ETHICS This Second Amended and Restated Code of Business Conduct and Ethics (the Code ) sets forth legal and ethical
Orange Guide (also known as the Field Guide)
Pfizer Inc 235 East 42nd Street New York, NY 10017 www.pfizer.com Dear Colleagues: At Pfizer, we are committed to upholding the highest standards when we interact with physicians, healthcare organizations,
Marshall University Joan C. Edwards School of Medicine Conflict of Interest Policy. Introduction
Marshall University Joan C. Edwards School of Medicine Conflict of Interest Policy Introduction The faculty 1 and medical students of the Joan C. Edwards School of Medicine (SOM) have responsibilities
International Transplant Nurses Society Speaker / Planner Bio Form
Ohio Nurses Association Biographical Data Form (2009 Criteria) Instructions: If you are a planner for this activity, complete Sections 1, 2, 4, 5 & 7. If you are a speaker/ content expert for this activity,
INTEGRITY IN ACTION - HEALTH CARE COMPLIANCE
A PASSION FOR INTEGRITY INTEGRITY IN ACTION - HEALTH CARE COMPLIANCE HEALTH CARE COMPLIANCE IS EVERYONE S RESPONSIBILITY DePuy Synthes is known the world over for innovative, life enhancing orthopedic
University of Miami Miller School of Medicine
University of Miami Miller School of Medicine Policy UMMG [University of Miami Medical Group] Policy: Pharmaceutical/Device Representative Interaction Division of Continuing Medical Education Website Date
LIBRARY GUIDE: Pharmaceutical Sales & Marketing
LIBRARY GUIDE: Pharmaceutical Sales & Marketing Page 2 Pharmaceutical Sales and Marketing Course Library Table of Contents: Courses Listed by Functional Area... 4 Basics of the PhRMA Code (PHSM01)...5
RE: NDA: 021876 DICLEGIS (doxylamine succinate and pyridoxine hydrochloride) delayed-release tablets, for oral use MA # 350 WARNING LETTER
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD 20993 TRANSMITTED BY FACSIMILE Eric Gervais, Executive Vice President 919 Conestoga Road Building
Guidance for Industry Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices
Guidance for Industry Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices DRAFT GUIDANCE This guidance document is being distributed for comment purposes
Advertising Compliance Questions and Answers by David Dickinson
Advertising Compliance Questions and Answers by David Dickinson This publication is not offered as legal advice. Readers should consult with legal counsel on specific fact situations. What Is An Advertisement?
How To Accredit A Continuing Education Program
POLICY AND PROCEDURES OFFICE OF EXECUTIVE PROGRAMS Accreditation -- Continuing Education Table of Contents PURPOSE...1 BACKGROUND...1 POLICY...3 RESPONSIBILITIES...7 PROCEDURES...7 REFERENCES...8 DEFINITIONS...8
HIPAA Privacy Rule Policies
DRAFT - Policies and Procedures PRIVACY OFFICE ASSIGNMENT AND RESPONSIBILITIES APPROVED BY: SUPERCEDES POLICY: Policy #1 ADOPTED: REVISED: REVIEWED: Purpose This policy is designed to assure the establishment
CMS Mandated Training for Providers, First Tier, Downstream and Related Entities
CMS Mandated Training for Providers, First Tier, Downstream and Related Entities I. INTRODUCTION It is the practice of Midwest Health Plan (MHP) to conduct its business with the highest degree of ethics
Regulatory Affairs Professionals Society: Regulatory Affairs Certification (RAC) Study Group FDA Regulation of Advertising and Promotion
Regulatory Affairs Professionals Society: Regulatory Affairs Certification (RAC) Study Group FDA Regulation of Advertising and Promotion Alex Toy July 14, 2013 1 Agenda FDA Regulatory Framework Office
1.3 There have been no material or substantive changes to the Code since last year.
1. Please describe the key components of the GPO s written code of business ethics and conduct. (Please provide a copy and describe any changes since the last submission.) Please assure your response includes:
University of Cincinnati College of Medicine
University of Cincinnati College of Medicine Policy Policy and Guidelines for Industry Relationships Policy and Guidelines for Industry Relationships FAQ Date Updated Page 5/14/2008 2 -- 8 NB: The Institute
Title: Gifts and Business Courtesies
Title: Gifts and Business Courtesies Effective Date: 5/04; Rev. 5/07 POLICY: Employees, (referred to as associates at some affiliates) officers and members of the Boards of Directors of Iowa Health System
Interplay Between FDA Advertising and Promotion Enforcement Activities, Product Liability, and Consumer Fraud Litigation
Interplay Between FDA Advertising and Promotion Enforcement Activities, Product Liability, and Consumer Fraud Litigation Leslie M. Tector Quarles & Brady LLP September 30, 2014 Objectives Which federal
MEDICAID AND MEDICARE (PARTS C&D) FRAUD, WASTE AND ABUSE TRAINING
MEDICAID AND MEDICARE (PARTS C&D) FRAUD, WASTE AND ABUSE TRAINING Why Do I Need Training/Where Do I Fit in? Why Do I Need Training? Every year millions of dollars are improperly spent because of fraud,
Fraud, Waste, and Abuse Training For Use By Care Wisconsin Providers Created: September 20, 2010 Reviewed/Revised: 8/18/2011
Fraud, Waste, and Abuse Training For Use By Care Wisconsin Providers Created: September 20, 2010 Reviewed/Revised: 8/18/2011 Definitions & Examples Why it Matters Prevention, Detection and Reporting Your
The following presentation was based on the
Fraud Waste and Abuse Presentation The following presentation was based on the Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training developed by the Centers for Medicare
Industry Sponsored Satellite Symposia Information and Application
Industry Sponsored Satellite Symposia Information and Application Dear ACOOG Annual Conference Exhibitor: Thank you for your interest in planning an Industry Supported Satellite Symposium in conjunction
CME Activity Development Guide TABLE OF CONTENTS
TABLE OF CONTENTS Introduction...4 Mission Statement...5 Office of CME...6 Definition of CME...7 ACCME Essentials...8 Certification for Category 1 Policies and Procedures Regularly Scheduled Conference...9
GSK Code of Practice for promotion and customer interactions
GSK Code of Practice for promotion and customer interactions Effective 21 July 2014 GSK Code of Practice GSK s interaction with external communities and the marketing of our products to ensure their appropriate
A Handbook for Planning Committees Developing Educational Programs
A Handbook for Planning Committees Developing Educational Programs Approved October 23, 2012 Educational Program Development Cycle Step 1 Convene planning committee Step 8 Review the evaluation results
HIGHMARK INC. THIRD PARTY CODE OF BUSINESS CONDUCT
HIGHMARK INC. THIRD PARTY CODE OF BUSINESS CONDUCT HIGHMARK.COM TABLE OF CONTENTS Overview...1 Highmark Inc. s Obligations to Third Parties...1 Highmark Inc. s Expectations for Third Parties...3 Highmark
Industry Hosted Events Space Request and Registration Form
Industry Hosted Events Space Request and Registration Form In an effort to provide excellent service to The Aesthetic Meeting attendees, The Aesthetic Society is requiring all exhibiting companies register
GUIDELINES FOR PHYSICIANS IN INTERACTIONS WITH INDUSTRY
CMA POLICY GUIDELINES FOR PHYSICIANS IN INTERACTIONS WITH INDUSTRY The history of health care delivery in Canada has included interaction between physicians and the pharmaceutical and health supply industries;
U.S. CORPORATE ETHICS AND COMPLIANCE POLICY
U.S. CORPORATE ETHICS AND COMPLIANCE POLICY Table of Contents Page 1. Letter from the President & CEO 3 2. Introduction 4 3. How to Handle and Report Ethical and/or Compliance Issues 5 3.1 Violations of
2012-2013 MEDICARE COMPLIANCE TRAINING EMPLOYEES & FDR S. 2012 Revised
2012-2013 MEDICARE COMPLIANCE TRAINING EMPLOYEES & FDR S 2012 Revised 1 Introduction CMS Requirements As of January 1, 2011, Federal Regulations require that Medicare Advantage Organizations (MAOs) and
MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations
MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations Pri-Med Institute Marissa Seligman, PharmD [email protected] DISCLAIMER: For informational
Compliance and Program Integrity Melanie Bicigo, CHC, CEBS [email protected] 906-225-7749
Compliance and Program Integrity Melanie Bicigo, CHC, CEBS [email protected] 906-225-7749 Define compliance and compliance program requirements Communicate Upper Peninsula Health Plan (UPHP) compliance
Updated HIPAA Regulations What Optometrists Need to Know Now. HIPAA Overview
Updated HIPAA Regulations What Optometrists Need to Know Now The U.S. Department of Health & Human Services Office for Civil Rights recently released updated regulations regarding the Health Insurance
HIPAA PRIVACY FOR EMPLOYERS A Comprehensive Introduction. HIPAA Privacy Regulations-General
HIPAA PRIVACY FOR EMPLOYERS A Comprehensive Introduction HIPAA Privacy Regulations-General The final HIPAA Privacy regulation was released on December 20, 2000 and was effective for compliance on April
FRAUD, WASTE & ABUSE. Training for First Tier, Downstream and Related Entities. Slide 1 of 24
FRAUD, WASTE & ABUSE Training for First Tier, Downstream and Related Entities Slide 1 of 24 Purpose of this Program On December 5, 2007, the Centers for Medicare and Medicaid Services ( CMS ) published
How to Conduct a Clinical Research Compliance Assessment
8 th Annual Pharmaceutical Regulatory Compliance Congress Track II Session November 8, 2007 How to Conduct a Clinical Research Compliance Assessment Elizabeth Jobes Deputy Compliance Officer Cephalon,
HIPAA Business Associate Contract. Definitions
HIPAA Business Associate Contract Definitions Terms used, but not otherwise defined, in this Agreement shall have the same meaning as those terms in the Privacy Rule. Examples of specific definitions:
o DOSAGE AND ADMINISTRATION Dosage in Special Populations: The recommended initial dose is 0.5 mg BID in patients who are elderly
Some critics of Janssen, including plaintiff s lawyers, have stated it is improper for Risperdal to have been used to treat elderly dementia patients. As you consider that position, we suggest you consider
Compliance Plan False Claims Act & Whistleblower Provisions Purpose/Policy/Procedures
CATHOLIC CHARITIES OF THE ROMAN CATHOLIC DIOCESE OF SYRACUSE, NY and TOOMEY RESIDENTIAL AND COMMUNITY SERVICES Compliance Plan False Claims Act & Whistleblower Provisions Purpose/Policy/Procedures Purpose:
BlueCross BlueShield of Tennessee Senior Care Division and Volunteer State Health Plan
BlueCross BlueShield of Tennessee Senior Care Division and Volunteer State Health Plan Fraud Waste and Abuse Training for Providers, First Tier, Downstream and Related Entities Overview The Centers for
SECTION 18 1 FRAUD, WASTE AND ABUSE
SECTION 18 1 FRAUD, WASTE AND ABUSE Annual FW&A Training Required for Providers and Office Staff 1 Examples of Fraud, Waste and Abuse 2 Fraud, Waste and Abuse Program Policy 3 Suspected Non-Compliance
MODULE II: MEDICARE & MEDICAID FRAUD, WASTE, AND ABUSE TRAINING
MODULE II: MEDICARE & MEDICAID FRAUD, WASTE, AND ABUSE TRAINING 2 0 1 4 Introduction The Medicare and Medicaid programs are governed by statutes, regulations, and policies PacificSource must have an effective
E-Commerce. INSU 2500 Chapter 5 Insurance Occupations INSURANCE OCCUPATIONS. Direct Marketing AGENT. Insurance Marketing and Distribution
E-Commerce INSU 2500 Chapter 5 Insurance Occupations Feb. 14, 2006 Convenience (i.e., 24-7). Cost-cutting; efficiencies. Price comparisons/shopping. Little or no human interaction. Auto and term life insurance
Health Care Compliance Association 888-580-8373 www.hcca-info.org
Volume Thirteen Number Six Published Monthly Meet Danna Teicheira, System Privacy Officer at St. Luke s Health System page 16 Earn CEU Credit www.hcca-info.org/quiz see page 19 Compliant DMEPOS telemarketing:
Healthcare Law Compliance Guide (commonly known as the White Guide)
Pfizer Inc 235 East 42nd Street New York, NY 10017 www.pfizer.com Dear Colleagues: At Pfizer, we are committed to upholding the highest standards when we interact with physicians, healthcare organizations,
Policies and Procedures SECTION:
PAGE 1 OF 5 I. PURPOSE The purpose of this Policy is to fulfill the requirements of Section 6032 of the Deficit Reduction Act of 2005 by providing to Creighton University employees and employees of contractors
Medicare Fraud, Waste, and Abuse Training for Healthcare Professionals 2010-2011
Medicare Fraud, Waste, and Abuse Training for Healthcare Professionals 2010-2011 Y0067_H2816_H6169_WEB_UAMC IA 11/22/2010 Last Updated: 11/22/2010 Medicare Requirements The Centers for Medicare and Medicaid
Healthcare Law Compliance Guide (commonly known as the White Guide)
Pfizer Inc 235 East 42nd Street New York, NY 10017 www.pfizer.com Dear Colleagues: At Pfizer, we are committed to upholding the highest standards when we interact with physicians, healthcare organizations,
MEDICAID AND MEDICARE (PARTS C&D) FRAUD, WASTE AND ABUSE TRAINING
MEDICAID AND MEDICARE (PARTS C&D) FRAUD, WASTE AND ABUSE TRAINING Why Do I Need Training/Where Do I Fit in? Why Do I Need Training? Every year millions of dollars are improperly spent because of fraud,
Robert A. Wade, Esq. Krieg DeVault LLP 4101 Edison Lakes Parkway, Ste. 100 Mishawaka, IN 46545 Phone: 574-485-2002 KD_4901979
False Claims Act Update Robert A. Wade, Esq. Krieg DeVault LLP 4101 Edison Lakes Parkway, Ste. 100 Mishawaka, IN 46545 Phone: 574-485-2002 Email: [email protected] KD_4901979 1 The FCA is the Fraud Enforcement
